The last paragraph in HQ's link:
Quote:
<snip>
On November 30, 2012, The Supreme Court agreed to hear a second
challenge to the two gene patents held by Myriad.[14]
Oral argument took place on April 15, 2013,
with a decision expected by the end of the Supreme Court's term in June.
|